. . . . . . . . . . . . "a(SCHEM:\"Very Low Density Lipoprotein\") -| r(HGNC:PLAT)" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "20131211" . "Secreted tPA antigen levels decreased approximately 53% (3.3+/-0.14 versus 6.97+/-0.42 microg/mL) and mRNA levels decreased approximately 70% in HTG-VLDL -treated HUVECs compared with NTG-VLDL-treated and culture medium control cells" . . "Selventa" . . . . "2014-07-03T14:31:35.756+02:00"^^ . . .